[1]
“Comparison of Deferasirox and Desferrioxamine as Iron Chelators in Multi-Transfused Pediatric Patients with Beta Thalassemia Major”, Pjmcr, vol. 4, no. 3, pp. 1214–1223, Aug. 2025, Accessed: Jun. 01, 2026. [Online]. Available: https://pakjmcr.com/index.php/1/article/view/126